Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism and Excretion of [14C]-TRV130 in Healthy Males
NCT02169934Phase 1Completed
- Sponsor
- Trevena, Inc.
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of oliceridine in acute pain, sponsored by Trevena, Inc. Primary endpoints: Pharmacokinetics of [14C]-TRV130, Plasma concentrations of total radioactivity and 3 more. Started Jun 2014; status: completed.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02169934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169934.